TY - JOUR T1 - Subcutaneous magnesium in the advanced cancer setting JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care SP - 191 LP - 193 DO - 10.1136/bmjspcare-2017-001360 VL - 8 IS - 2 AU - Stephen J Fenning AU - Steinunn R Boyce AU - Paul Wilson AU - Fran Stretton Y1 - 2018/06/01 UR - http://spcare.bmj.com/content/8/2/191.abstract N2 - Hypomagnesaemia can arise from a variety of causes but is particularly prevalent in cancer populations. This case report describes a patient with recurrent symptomatic hypomagnesaemia, on the background of advanced ovarian cancer and a high-output ileostomy, who was successfully managed on a daily continuous subcutaneous infusion of magnesium via a syringe pump. There is limited published information on the subcutaneous administration of magnesium and, to our knowledge, this is the first case to report its routine delivery over 24 hours in a syringe pump. This novel but effective approach for administering magnesium can be delivered in the community and can, therefore, prevent repeated hospital admissions for patients with recurrent symptomatic hypomagnesaemia who would otherwise need intravenous replacement. ER -